within Pharmacolibrary.Drugs.ATC.C;

model C01EB09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01EB09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ubidecarenone, also known as coenzyme Q10 (CoQ10) or ubiquinone, is a naturally occurring antioxidant used as a dietary supplement and adjunctive therapy in cardiovascular diseases such as heart failure and angina pectoris. It plays a critical role in mitochondrial electron transport and cellular energy production. While available in some countries as a prescription or over-the-counter product, its approval status for specific indications varies globally.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for an adult population receiving oral ubidecarenone, as no direct population PK fitting is available in published biomedical literature.</p><h4>References</h4><ol><li><p>Garrido-Maraver, J, et al., &amp; Sanchez-Alcazar, JA (2014). Clinical applications of coenzyme Q10. <i>Frontiers in bioscience (Landmark edition)</i> 19(4) 619–633. DOI:<a href=&quot;https://doi.org/10.2741/4231&quot;>10.2741/4231</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24389208/&quot;>https://pubmed.ncbi.nlm.nih.gov/24389208</a></p></li><li><p>López-Lluch, G, et al., &amp; Navas, P (2019). Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. <i>Nutrition (Burbank, Los Angeles County, Calif.)</i> 57 133–140. DOI:<a href=&quot;https://doi.org/10.1016/j.nut.2018.05.020&quot;>10.1016/j.nut.2018.05.020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30153575/&quot;>https://pubmed.ncbi.nlm.nih.gov/30153575</a></p></li><li><p>Díaz-Casado, ME, et al., &amp; López, LC (2024). Oral β-RA induces metabolic rewiring leading to the rescue of diet-induced obesity. <i>Biochimica et biophysica acta. Molecular basis of disease</i> 1870(7) 167283–None. DOI:<a href=&quot;https://doi.org/10.1016/j.bbadis.2024.167283&quot;>10.1016/j.bbadis.2024.167283</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38851305/&quot;>https://pubmed.ncbi.nlm.nih.gov/38851305</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01EB09;
